C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2004
11/17/2004	EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476154A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
11/17/2004	EP1412335A4 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
11/17/2004	EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1066264B1 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	CN1547572A Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate
11/17/2004	CN1176078C Sulfenylation process of pyrazole compounds with trifluoromethane sulfenyl group
11/16/2004	US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/16/2004	US6818622 Selective MMP inhibitors having reduced side-effects
11/16/2004	US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
11/16/2004	CA2145181C Process for preparing 1-2,-substituted-5-formylimidazoles
11/11/2004	WO2004097406A2 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096776A1 Method for the production of ionic liquids containing alkyl sulphate and functionalised alkyl sulphate-anions
11/11/2004	WO2004096213A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/11/2004	WO2004063152A3 Lansoprazole formulations and related processes and methods
11/11/2004	US20040225157 for aliphatic, aromatic, heterocycle aromatic compounds
11/11/2004	US20040225131 reacting formaldehyde with alkylamine; acidification in water, glyooxal solution; separation
11/11/2004	US20040224993 Diphenylurea compounds
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	CA2522817A1 Imidazolin-2-ylaminophenyl amides as ip antagonists
11/10/2004	EP1475370A1 Optically active azole derivative and process for producing the same
11/10/2004	EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004	EP0859764B1 PROCESS FOR THE CONTINUOUS PRODUCTION OF BASIC CYCLIC OPTICALLY ACTIVE alpha-AMINO ACIDS
11/10/2004	CN1544421A Aphid alarm pheromone E-beta-Farmesene nitrogenous analog and its preparation method
11/10/2004	CN1174967C Method for production of caprolactam
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815445 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
11/04/2004	WO2004094395A2 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004083185A3 Phenyl substituted imidazole derivatives
11/04/2004	WO2004067703A3 5ht7 antagonists and inverse agonists
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220410 Method for preparing beta-alanine amides
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220247 N-[4-(4,5-Dihydro-1H-imidazol-2-yl-amino)-benzyl]-4-methoxy-benzamide and derivatives; prostaglandin inhibitors; urinary tract disease, disease related pain, neuropathic pain, respiratory asthma, allergy
11/04/2004	US20040220237 Asthma and allergic inflammation modulators
11/04/2004	US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
11/04/2004	CA2522476A1 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
11/03/2004	EP1472260A2 Thieno(3,2-b)pyridones as antiviral compounds
11/03/2004	EP1472232A1 Processes for preparing imidazole derivatives and salts thereof
11/03/2004	EP1472231A1 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
11/03/2004	EP1472217A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1472201A2 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
11/03/2004	EP1317425B1 Resorcinol derivatives
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1543311A Selective substituted aryl ketone and safener based herbicides
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1173955C Process for preparing ketone condensate of L-(+)-2-amino-1-p-nitrophenyl-1,3-propanediol
11/03/2004	CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/02/2004	US6812349 Process and intermediates for the preparation of imidazopyridines
11/02/2004	US6812257 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
11/02/2004	US6812256 Reducing weight in mammals; anorectic action
11/02/2004	US6812237 (arylaminoaceamido)acetonitrile derivatives
11/02/2004	US6812231 Inhibiting activated blood-coagulation factor x
11/02/2004	CA2129040C Styryl derivatives and processes for their preparation
10/2004
10/28/2004	WO2004092447A2 Imidazoline corrosion inhibitors
10/28/2004	WO2004092224A2 Polymerisation initiator system
10/28/2004	WO2004092141A1 1-imidazolymethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing
10/28/2004	WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092100A1 Indene derivatives as pharmaceutical agents
10/28/2004	WO2004091610A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004	WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004	WO2004058726A3 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214875 Imidazolinylmethyl aralkylsulfonamides
10/28/2004	US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
10/28/2004	US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004	US20040214218 inclusion or cluster compounds used for DNA compaction and gene therapy
10/28/2004	US20040211012 For example, 1-(2-(3-hydroxy-4-methyl-phenylamino)-ethyl)-3 methyl 3-H-imidazol-1-ium chloride; prepared by reacting an aminophenol with a haloacetyl chloride, reducing product with borane-tetrahydrofuran complex, reacting compound with amine
10/28/2004	US20040211011 Primary intermediates for oxidative coloration of hair
10/28/2004	CA2527170A1 Therapeutic compounds
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521883A1 Indene derivatives as pharmaceutical agents
10/28/2004	CA2521841A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004	CA2521502A1 Imidazoline corrosion inhibitors
10/27/2004	EP1471056A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
10/27/2004	EP1470136A1 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
10/27/2004	EP1470095A1 Method for producing alkenyl aromatic compounds
10/27/2004	EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004	EP0970073B1 Process for preparing eprosartan
10/27/2004	EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004	CN1541215A HIV inhibiting pyrimidines derivatives
10/27/2004	CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004	CN1541207A Dyeing compsn. for kerationous fibres comprising particular dicationic diazo dye
10/27/2004	CN1541099A Arylazo-substituted imidazole for treatment of stress urinary incontinence
10/27/2004	CN1541086A Dyeing compson. for kerationous fibres comprising particular dicationic diazo dye

1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 345